Finance AlphaSpace
48 results found
-
Historical Intraday Options Chain Data with Greeks
Please add historical intraday options-chain data to AlphaSpace/Yahoo Scout for quantitative options research and strategy backtesting.
I would like the ability to select any historical date, underlying symbol, expiration, strike, and call/put contract and retrieve timestamped intraday snapshots, ideally at 1-minute intervals (5-minute would still be useful).
Each historical snapshot should include:
• Bid, ask, midpoint and last price
• Bid/ask size
• Strike and expiration
• Call/put
• Underlying price at that timestamp
• Delta, gamma, theta and vega
• Implied volatility
• Volume and open interest
• Expected move, if availableThe most valuable feature would be the…
1st ranked -
Please remove the search widget at the bottom of the screen
leave the viewing area open so we can see each pane fully
1st ranked -
Eport Yahoo Scout research to google doc
Yahoo Finance Gold Alpha is an invaluable tool for my deep financial research. I have had some great chats that I want to build on in my economic plan document. Need to have an export feature that users can retrieve using Google Doc.s
1st ranked -
News feed accuracy
News feed accuracy — watchlist-scoped news panel surfacing off-topic (non-biopharma) news including tech stories despite all tickers being biopharma/biotech; news engine should filter strictly to ticker-relevant content
1st ranked -
Bug fix in top ETF template
From Yahoo Scout: "Here's the issue: the Top ETFs panel's source is set to kind: "sector" with sectorKey: "technology" but has no quoteType filter. The Top Companies panel explicitly sets quoteType: "EQUITY", and the Top Mutual Funds panel explicitly sets quoteType: "MUTUALFUND" — but Top ETFs is missing its quoteType: "ETF" filter entirely. That's why it's falling back to showing stocks.". Click on any theme (AI & Tech for example), change the source settings: it will show stock themes and sectors. Once selected, there is no way to go back to "TOP ETFS".
1st ranked -
1st ranked
-
Heatmap sized by holding's market value
I would like to see a heat map that has the tiles sized by my holding's market value. I think it can only do my market cap now. Thanks!
1st ranked -
Add Auto-markings on price chart.
In Yahoo Finance, I have been manually adding color-coding horizontal lines at the price levels i make buys (color A) and sells (color B). and i add the average cost/share (Color C). This way I can see at a glance what min levels sell at and max levels to buy at to make it a prudent transaction.
I think this would be a helpful tool to add to Alpha Space. When pulling buy and sell transactions from Yahoo Finance portfolios, assuming you're storing these in a database, when refreshing the Alpha Space, check if the user has auto-markings enabled and…
1st ranked -
Options details in portfolios
Options and ETF in portfolios especially in the alphaspace should not show up as "other" when looking at portfolios. Portfolio insights and risk and sectors only show for equities. The options and ETFs should also have categories assigned to them based on the underlying stock for the options and the etfs should be allocated according to holdings. If something shows up as "other" alphaspace had work to do.
1st ranked -
Combined Portfolios
I would really appreciate the ability to combine multiple portfolios without having to combine ALL portfolios. For example, I would love to combine 3 of my work portfolios into one View and combine the other 8 personal portfolios for one view.
1st ranked -
Watchlist sorting options
Watchlist sorting options — ability to sort tickers alphabetically, by market cap, by % change, by sector, or by custom drag-and-drop order
48th ranked -
AlphaSpace for masses
AlphaSpace could enable masses to invest better if it evolves toward a FactSet-level biopharma research experience — with analyst-level estimates, product revenue breakdowns, specialist fund tracking, and pipeline catalyst monitoring built into a single workflow
1st ranked -
Estimates
Individual analyst names with their specific EPS, revenue, R&D, and SG&A estimates broken out in the consensus estimates panel 2.C onsensus estimates panel should include analyst averages for R&D and SG&A line items, not just EPS and revenue — especially critical for biopharma where R&D spend is a primary value driver
1st ranked -
Product/asset-level revenue breakdown panel
Product/asset-level revenue breakdown panel — both reported actuals and analyst consensus estimates per drug — critical for biopharma where a single asset like Keytruda or Ozempic can drive the majority of company value
1st ranked -
Institutional investors/shareholders panel
Institutional investors/shareholders panel — live panel showing top holders, ownership percentage, and quarter-over-quarter changes for a focused ticker
1st ranked -
Fund directory panel
Fund directory panel — curated list of specialist biopharma/healthcare investors with their latest 13F summary, AUM in biopharma, and top holdings, clickable to drill into their full position list
1st ranked -
13F investor panel
13F investor panel — track position changes from named specialist biopharma funds (RA Capital, Baker Brothers, ARK Invest, Perceptive Advisors, Orbimed) with their latest filings, new positions, additions, reductions, and exits, filtered by watchlist tickers
1st ranked -
SEC filings panel
SEC filings panel — dedicated panel surfacing 10-K, 10-Q, and 8-K filings for a focused ticker directly in the view
1st ranked -
SEC filings panel
SEC filings panel — dedicated panel surfacing 10-K, 10-Q, and 8-K filings for a focused ticker directly in the view
1st ranked -
Short interest
Short interest panel showing short interest, days to cover, and short interest change over time for individual tickers
1st ranked
- Don't see your idea?